Scholarlink

<p>Increasing evidence indicates that regulated cell death (RCD), such as apoptosis, anoikis, autophagy, pyroptosis, necroptosis, ferroptosis and cuproptosis, plays crucial roles in renal tissue injury and the progression of fibrosis by promoting inflammatory responses and extracellular matrix deposition. Therefore, elucidating the molecular mechanisms of different types of RCD is essential for treating patients with renal fibrosis. This review comprehensively presents the distinct and interactive roles of RCD in renal fibrosis pathogenesis and elucidates the crosstalk among different forms of RCD and core fibrotic signaling pathways. Moreover, we analyzed clinically promising RCD-related therapeutic targets and identified future research directions, thereby providing a theoretical basis for the clinical treatment of renal fibrosis patients. To mitigate the threat of compensatory crosstalk between RCD pathways during clinical translation, the development of drugs that simultaneously target multiple forms of RCD may offer a novel approach for precise renal fibrosis treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Regulated cell death: a multidimensional regulatory network in the pathogenesis of renal fibrosis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月24日

查看全文
  • Wen Li,
  • Liang Zhou,
  • Jinji Zhang,
  • Jingying Sun,
  • Qing Feng,
  • Kunyi Wu,
  • Na Zhu

摘要

Increasing evidence indicates that regulated cell death (RCD), such as apoptosis, anoikis, autophagy, pyroptosis, necroptosis, ferroptosis and cuproptosis, plays crucial roles in renal tissue injury and the progression of fibrosis by promoting inflammatory responses and extracellular matrix deposition. Therefore, elucidating the molecular mechanisms of different types of RCD is essential for treating patients with renal fibrosis. This review comprehensively presents the distinct and interactive roles of RCD in renal fibrosis pathogenesis and elucidates the crosstalk among different forms of RCD and core fibrotic signaling pathways. Moreover, we analyzed clinically promising RCD-related therapeutic targets and identified future research directions, thereby providing a theoretical basis for the clinical treatment of renal fibrosis patients. To mitigate the threat of compensatory crosstalk between RCD pathways during clinical translation, the development of drugs that simultaneously target multiple forms of RCD may offer a novel approach for precise renal fibrosis treatment.